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Endothelial glycocalyx degradation induced by fluid
overload adds to the concern of a detrimental effect
of uncontrolled fluid resuscitation and the risk of
unnecessary fluid infusion. As a consequence, the use
of new tools for monitoring response to fluids appears
promising. From that perspective, the monitoring of
plasma concentration of glycocalyx degradation
markers could be useful.elective surgery induced a release of atrial natriureticFluid resuscitation is common practice for patients with
hypovolemia and is recommended as first-line treatment
for septic shock. However, accumulating evidence suggests
that uncontrolled fluid loading may be detrimental. In that
respect, the study by Chappell and colleagues [1] in the
previous issue of Critical Care adds an important piece of
information to the debate over the need for careful moni-
toring of patients in order to avoid unnecessary fluids.
During peri-operative management, Chappell and col-
leagues prospectively explored the consequences of acute
volume loading on endothelial functions and hypothesized
that high-volume infusion could alter endothelial glyco-
calyx. The glycocalyx consists of a variety of endothelial
membrane-bound molecules, including glycoproteins and
proteoglycans that form a negatively charged barrier to
circulating cells and macromolecules [2]. Numerous ani-
mal studies have demonstrated that destruction of the gly-
cocalyx (using enzymatic approaches, for example) leads
to increased capillary permeability [3]. In vivo, degradation
of the glycocalyx with heparinase favors tight contacts* Correspondence: bertrand.guidet@sat.aphp.fr
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through denudation of the protective barrier that normally
prevents this effect [4]. In addition, the glycocalyx parti-
cipates in the coagulation process as heparan sulfate and
dermatan sulfate, two glycocalyx glycosaminoglycans, po-
tentiate the activity of two anticoagulant enzymes: anti-
thrombin III (by a factor of 100) and heparin cofactor II,
respectively (reviewed in [5]).
Chappell and colleagues reported that volume loading
(20 mL/kg of hydroxyethyl starch (HES) 130/0.4) in
peptide (ANP) associated with an increase of serum gly-
cocalyx components (syndecan-1 and hyaluronan) but
that there was no effect of acute normovolemic hemodi-
lution. The augmentation of these plasma components
suggests a degradation of endothelial glycocalyx that could
promote vascular leakage, leukocyte adhesion, and pro-
coagulant status. However, this is a speculative and physio-
pathological conclusion, and the authors did not provide
any direct evidence of glycocalyx functional alteration. The
twofold increase of serum syndecan-1 concentration after
volume overload is statistically significant but was very far
from the 10-fold increase reported during septic shock [6]
and the 40-fold increase after aortic surgery [7].
The mechanisms of glycocalyx shedding have not been
directly investigated, but the authors proposed that ANP
could be implicated. This hypothesis is based on a previ-
ous experimental study by the same group [8] and the
observation of a simultaneous plasma increase of ANP
and glycocalyx components during volume overload. Other
mechanisms of shedding have been proposed [5], such as
the activation of circulating enzymes (heparinase, neura-
minidase, and pronase), the release of pro-inflammatory
cytokines (tumor necrosis factor-alpha), or the direct effect
of increased shear stress on the arterial endoluminal wall.
Finally, reactive oxygen species could also induce glycos-
aminoglycans release. As albumin has anti-oxidant proper-
ties [9], one can speculate that volume resuscitation usingd Central Ltd. The licensee has exclusive rights to distribute this article, in any
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recent trial suggests that albumin could reduce mor-
tality in the most severe cases of septic shock [10].
The mechanisms of the potential beneficial effect of
albumin remain unclear. An interaction of albumin
with the glycocalyx leading to a reduction of the capillary
leak is a seductive hypothesis but should be further inves-
tigated [11].
This translational study gives interesting insights into
the deleterious effects of fluid infusion in critically ill pa-
tients. Indeed, accumulative clinical studies pointed out
that positive fluid balance and weight gains are associ-
ated with a worse prognosis [12] but the mechanisms of
this deleterious effect remain unknown. Fluid accumula-
tion within the tissue could alter the diffusion of oxygen,
promoting hypoxic cellular injury. Fluid resuscitation is
recommended as a first-line treatment, particularly dur-
ing the first hour [13], but the volume and type of fluid
that should be used remain controversial. The choice of
fluid should be integrated in a dynamic process (rescue,
optimization, stabilization, and de-escalation) [14]. Recent
trials have added to the confusion regarding the usefulness
of an algorithm guiding hemodynamic management of
shock [15] and the mean arterial pressure that should be
targeted [16]. Three criteria should be present: evidence
of fluid responsiveness such as pulse pressure variation;
presence of signs of tissue hypoperfusion; and absence of
fluid overload. Stopping rules are either no fluid respon-
siveness or absence of signs of tissue hypoperfusion or
presence of fluid overload. We need to set clinically rele-
vant goals. From that perspective, an integrative approach
looking at simple indices of tissue perfusion and microcir-
culation could be useful at the bedside [17,18], although
so far no interventional study has proven that such a strat-
egy is able to improve the outcome. The protection or res-
toration of glycocalyx might be considered an important
goal [19]. The place of glycocalyx degradation components
remains to be assessed, but they could represent a surro-
gate marker for physicians to identify vascular endothelial
injury and ultimately to limit fluid overload. A respectful
strategy for the glycocalyx may decrease the capillary leak
and improve tissue oxygenation just by giving the right
amount of fluids and maybe by choosing fluids with no
impact on glycocalyx degradation.
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